Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Glaxo Chair To Exit; William Hill Profit Down

Mon, 21st Jan 2019 07:59

LONDON (Alliance News) - Stock prices in London are set for a marginally higher open on Monday, with investors optimistic about US-China trade relations and hopeful for economic stimulus in China following weak 2018 growth figures.IG futures indicate the FTSE 100 index is to open 11.0 points higher at 6,979.33. The blue-chip index closed up 133.41 points, or 2.0%, at 6,968.33 on Friday. "Asian markets traded higher on Chinese stimulus hopes following slowing GDP growth. Investors also demonstrated confidence that trade tensions would ease as they looked towards talks later this month with optimism," said London Capital Group analyst Jasper Lawler.China's economy grew 6.6% in 2018, the country's statistics bureau said Monday, in the slowest rate since 1990.In the final quarter of 2018, the economy grew 6.4% amid signs the world's second-largest economy is slowing as China grapples with issues including the ongoing trade war with the US.Growth for 2019 is widely expected to fall to 6.5% or lower, according to the World Bank and economic experts.Premier Li Keqiang said Thursday that China would aim to keep growth within a "reasonable range" through innovation and macroeconomic policies, according to state news agency Xinhua.The economy has taken a hit from the US trade war, which if left unresolved past its March deadline for negotiations could further inhibit growth.The Japanese Nikkei 225 index ended up 0.3% Monday. In China, the Shanghai Composite ended up 0.6%, while the Hang Seng index in Hong Kong is up 0.4% in late trade.US markets will be closed Monday for the Martin Luther King Jr Day holiday. On Friday, Wall Street ended higher, with the Dow Jones Industrial Average closing 1.4% higher, the S&P 500 up 1.3%, and the Nasdaq Composite 1.0% higher.In early UK corporate news, the blue-chip pharmaceutical company GlaxoSmithKline said Non-Executive Chairman Philip Hampton will step down and the search for his successor has begun."Following the announcement of our deal with Pfizer Inc and the intended separation of the new consumer business, I believe this is the right moment to step down and allow a new chair to oversee this process through to its conclusion over the next few years and to lead the board into this next phase," Hampton said.In December, Glaxo announced that it will combine its consumer healthcare business with that of the US's Pfizer, creating a new joint venture. The combination will have sales of GBP9.8 billion, and GSK will have a majority controlling equity interest of 68%.Turning to London mid-caps, William Hill said it expects its adjusted operating profit for the year to January 1 to be GBP234 million, down 15% on the year prior. The result is in line with the betting company's operating profit guidance of GBP225 million to GBP245 million. More positively for William Hill, underlying operating profit increased 4% year-on-year, with the Online division delivering good growth. The company has also highlighted an "excellent" growth in the US and said it plans to invest in rapid expansion in the country.Separately, William Hill said it now holds 92% stake in online gambling company Mr Green & Co, and expects to secure the acceptances of its takeover offer for the remaining 8% interest by the end of January.Meanwhile, takeaway food delivery marketplace Just Eat said Chief Executive Officer Peter Plumb is stepping down from the board with immediate effect, and will be replaced by Chief Customer Officer Peter Duffy until the appointment of successor. The company also said that 2018 has been a transformational year, and it expects to report annual orders of 221 million, with revenue of GBP780 million, up from GBP546 million generated in 2017. Underlying earnings before interest, taxes, depreciation, and amortization is anticipated to total between GBP172 million and GBP174 million. In 2017, Just Eat reported underlying Ebitda of GBP164 million. Looking ahead, Just Eat expects to invest in the significant opportunity it sees in the high-growth markets of Brazil and Mexico. It also sees 2019 revenue in a range of GBP1.0 billion to GBP1.1 billion and underlying Ebitda of GBP185 million to GBP205 million. Components firm Meggitt said it signed a USD750 million contract with Pratt & Whitney to continue the supply of advanced composite components for the F119 and F135 engines which power the F-22 Raptor and F-35 Lightning II aircraft."These components will be produced in our new state-of-the-art facility in San Diego, California which opened in August 2018 to support the rapid growth in demand for advanced engine composite components across the aerospace industry," said Meggitt Chief Executive Tony Wood.Elsewhere, Patisserie Holdings confirmed it is still in talks with its bankers to extend the standstill of its bank facilities beyond January 18. On Sunday, The Times reported that the cake chains main trading subsidiary Patisserie Valerie has a potential to collapse as soon as Tuesday if emergency talks between major shareholder Luke Johnson and its lenders fail.The newspaper said Patisserie Valerie's Chair Johnson intends to extend a standstill agreement on the cake chain's bank facilities, which expired on Friday last week. If he fails, HSBC Holdings and Barclays could demand repayment of GBP9.7 million of overdraft debt.Turning to Brexit, May is to set out her next steps to build a Commons majority for a Brexit deal amid signs she is still unwilling to give ground on her central demands.Following the crushing defeat last week of her agreement with Brussels, the prime minister will make oral and written statements to the House explaining how she intends to proceed.She will also table a "neutral" motion to be debated and voted on - along with any amendments tabled by MPs - on January 29.Government sources said she would be holding further talks with MPs, as well as business leaders and trade unionists, throughout the week in an attempt to find a way forward.But after she briefed the Cabinet in a conference call on Sunday about her first round of cross-party contacts last week, there was little expectation she was ready to offer concessions that could win over opposition MPs.The pound was lower, quoted at USD1.2870 early Monday, soft compared to USD1.2897 at the close Friday.The economic events calendar Monday will see world leaders gather in Davos, Switzerland for the World Economic Forum starting on Tuesday.

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.